Enterprise Products Partners L.P. (EPD)

Enterprise Products Partners is trading in the middle of its 52-week range, at $37.13, and sitting almost exactly on its 20-day exponential average. The stock is 0.76% below its 50-day average and 0.85% below its 200-day average, so the trend reads as down even though the last month has been positive. The debate for investors is whether a business with 49.30% year-on-year revenue growth and a 12.29 trailing P/E can break out of a range that has held since the stock traded between $31.35 and $40.17 over the past year.

Enterprise Products reported adjusted EPS of $0.76 on October 29, 2026, against an analysts' estimate of $0.73, a beat of 4.11%. The stock fell 2.30% in the first session after the report. Across the seven most recent reports, the company beat the EPS estimate four times, and in two of those four cases the share price was lower in the first session. The October 30, 2025 report was a miss of 3.08%, and the stock fell 2.50% the following session. The pattern shows that the market has been reacting more to the outlook and the balance sheet than to the headline quarter.

At $37.13, the stock trades at a trailing P/E of 12.29, a discount to peers, against a sector median of 18.4, which puts it 33.2% below the group. The price-to-sales ratio of 1.24 compares with a sector median of 2.5, a gap of 50.4%. Trailing reported earnings per share are $3.02, and the dividend yield is 5.98% on an annual dividend of $2.22 per share. Debt-to-equity is 1.10. Those figures explain why the valuation scores so highly in CleaRank's view, even as the price has not moved much over the past year.

Insiders have made no sales in the last 18 months, while four open-market purchases totalled $1.6M over the same period. On the Street side, 10 of 23 analysts rate the stock buy or strong buy, 12 rate it hold and 1 rates it sell or strong sell. That is a shift from three months ago, when 11 of 21 rated it buy. The most recent action was Truist Securities keeping its Hold rating on October 30, 2026. Morgan Stanley's Underweight rating, kept on August 18, 2026, is the only sell-side view below neutral among the analysts covering the stock.

The base case is that the stock keeps trading in the middle of its range while it works through the cluster of averages sitting just above the price, between $37.41 and $37.45. Earnings have beaten the estimate in four of the last seven reports, but the share price fell the session after the October 29, 2026 report, so the market has not yet paid for those beats. A move back above the two averages, with the 52-week high at $40.17 as the next target, would require the stock to hold above that cluster on a sustained basis. A break below the 52-week low at $31.35 would reverse the picture. Analysts' median 12-month target is $42.00, with a range of $38.00 to $47.00, which sits above the current price. Analysts' average EPS estimate for 2026 is $3.04, expected to grow 13.3%, and $3.17 for 2027, expected to grow 4.6%, so the forward earnings path is positive but slower in the second year.

Support: The 52-week low at $31.35 is the nearest level below the price and the first level a fall would meet. Resistance: The 20-day exponential average at $37.10 sits right at the price. Above it, the 50-day simple moving average at $37.41 is the nearest level, followed by the 200-day simple moving average at $37.45, which sits just above it. The 52-week high at $40.17 is the furthest resistance on the chart. The cluster of the 50-day and 200-day averages is the zone where a rise would first be tested.